Abstract:Objective Inferring cancer driver genes, especially rare or sample-specific cancer driver genes, is crucial for precision oncology. Considering the high inter-tumor heterogeneity, a few recent methods attempt to reveal cancer driver genes at the individual level. However, most of these methods generally integrate multi-omics data into a single biomolecular network (e.g., gene regulatory network or protein-protein interaction network) to identify cancer driver genes, which results in missing important interactions highlighted in different networks. Thus, the development of a multiplex network method is imperative in order to integrate the interactions of different biomolecular networks and facilitate the identification of cancer driver genes.Methods A multiplex network control method called Personalized cancer Driver Genes with Multiplex biomolecular Networks (PDGMN) was proposed. Firstly, the sample-specific multiplex network, which contains protein-protein interaction layer and gene-gene association layer, was constructed based on gene expression data. Subsequently, somatic mutation data was integrated to weight the nodes in the sample-specific multiplex network. Finally, a weighted minimum vertex cover set identification algorithm was designed to find the optimal set of driver nodes, facilitating the identification of personalized cancer driver genes.Results The results derived from three TCGA cancer datasets indicate that PDGMN outperforms other existing methods in identifying personalized cancer driver genes, and it can effectively identify the rare driver genes in individual patients. Particularly, the experimental results indicate that PDGMN can capture the unique characteristics of different biomolecular networks to improve cancer driver gene identification.Conclusion PDGMN can effectively identify personalized cancer driver genes and broaden our understanding of cancer driver gene identification from a multiplex network perspective. The source code and datasets used in this work are available at https://github.com/NWPU-903PR/PDGMN.

Multi-modal Optimization to Identify Personalized Biomarkers for Disease Prediction of Individual Patients with Cancer

Latent space search based multimodal optimization with personalized edge-network biomarker for multi-purpose early disease prediction

Multi-omics with Dynamic Network Biomarker Algorithm Prefigures Organ-Specific Metastasis of Lung Adenocarcinoma

A Multiplex Network Control Method for Identifying Personalized Cancer Driver Genes

Multi-objective Optimization-Based Approach for Detection of Breast Cancer Biomarkers.

Multimodal Survival Ensemble Network: Integrating Genomic and Histopathological Insights for Enhanced Cancer Prognosis.

Multi-Objective Optimization Based Network Control Principles for Identifying Personalized Drug Targets With Cancer

Multi-parameter systematic strategies for predictive, preventive and personalised medicine in cancer

Network-based Multi-Task Learning Models for Biomarker Selection and Cancer Outcome Prediction.

Constrained Multi-objective Optimization-Based Temporal Network Observability for Biomarker Identification of Individual Patients

Identification of Pan-Cancer Prognostic Biomarkers Through Integration of Multi-Omics Data

Integrative data analysis of multi-platform cancer data with a multimodal deep learning approach

Extracting Stage-Specific and Dynamic Modules Through Analyzing Multiple Networks Associated with Cancer Progression

DM-MOGA: a multi-objective optimization genetic algorithm for identifying disease modules of non-small cell lung cancer

NNBGWO-BRCA marker: Neural Network and binary grey wolf optimization based Breast cancer biomarker discovery framework using multi-omics dataset

A Multi-Objective Optimization Method for Identification of Module Biomarkers for Disease Diagnosis

A Multi-Source Fusion Method to Identify Biomarkers for Breast Cancer Prognosis Based on Dual-Layer Heterogeneous Network.

A network medicine approach for identifying diagnostic and prognostic biomarkers and exploring drug repurposing in human cancer

Identification of breast cancer risk modules via an integrated strategy